Latest filing published 06 Feb 2014 for Eiger BioPharmaceuticals, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Joshua Funder: trading record in brief
Joshua Funder discloses dealings in Eiger BioPharmaceuticals, Inc. to SEC (Form 4). The record holds 3 filings, all for trades on 4 February 2014.
Purchases make up the whole of the open-market record (1 purchase, €1.3M). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The record was last updated on 6 February 2014 with a transaction in Eiger BioPharmaceuticals, Inc. The most recent open-market purchase was published on 6 February 2014, 4,659 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Joshua Funder
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 943,798 sharesCommon StockSEC:0001209191-14-007971:0
- 23,145 shares@ US$8.00Common StockSEC:0001209191-14-007971:1
- 227,261 shares@ US$8.00Common StockSEC:0001209191-14-007971:2Canonical exit: 5 May 2014 (T+90)
3 of 3 declarations
